Jonathan Allan Stoke Therapeutics, Inc. (STOK) insider trading activity

STOK Quotes by TradingView

Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. Currently has a direct ownership of 2,598 shares of STOK, which is worth approximately $34,475. The most recent transaction as insider was on May 20, 2024, when has been sold 8,599 shares (Common Stock) at a price of $15.04 per share, resulting in proceeds of $129,328. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.6K
0% 3M change
Infinity% 12M change
Total Value Held $34,475

Jonathan Allan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Open market or private sale
$129,328 $15.04 p/Share
8,599 Reduced 76.8%
2,598 Common Stock
May 20 2024
BUY
Exercise of conversion of derivative security
$60,794 $7.07 p/Share
8,599 Added 43.44%
11,197 Common Stock
Mar 28 2024
SELL
Open market or private sale
$69,201 $13.5 p/Share
5,126 Reduced 66.36%
2,598 Common Stock
Mar 19 2024
SELL
Open market or private sale
$14,328 $6.1 p/Share
2,349 Reduced 23.32%
7,724 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
7,475 Added 42.6%
10,073 Common Stock
Jun 21 2023
SELL
Open market or private sale
$26,259 $13.48 p/Share
1,948 Reduced 100.0%
0 Common Stock
JA

Jonathan Allan

GENERAL COUNSEL & CORP SEC
Bedford, MA

Track Institutional and Insider Activities on STOK

Follow Stoke Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

News

Receive news related to Stoke Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on STOK